Optimization of Lipoplexes Functionalized with a Sialic Acid Mimetic (F9-PEG) to Target the C1858T <i>PTPN22</i> Variant for Preclinical Assessment of a Novel Immunotherapy in Endocrine Autoimmunity

<b>Background:</b> The C1858T <i>PTPN22</i> variant is strongly associated with type 1 diabetes and autoimmune thyroid disease. Current treatment is substitutive hormonal administration, which does not target the disease pathogenetic mechanism. We previously implemented a novel immunotherapy, employ...

Täydet tiedot

Bibliografiset tiedot

Päätekijät:	Simona Sennato, Giorgia Paldino, Cecilia Bombelli, Irene Mezzani, Stefania Petrini, Eugenia Belcastro, Domenico Vittorio Delfino, Francesco Fiorentino, Carlotta Marianecci, Alessia Ciogli, Dante Rotili, Francesca Ceccacci, Alessandra Fierabracci
Aineistotyyppi:	Artigo
Kieli:	Inglês
Julkaistu:	MDPI AG 2025-05-01
Sarja:	Pharmaceutics
Aiheet:	type 1 diabetes endocrine autoimmunity immunotherapy variant <i>PTPN22</i> lipoplexes optimization
Linkit:	https://www.mdpi.com/1999-4923/17/6/710
Tagit:	Lisää tagi Ei tageja, Lisää ensimmäinen tagi!